Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms

This study has been completed.

Sponsor:

Information provided by:

National Institutes of Health Clinical Center (CC)

ClinicalTrials.gov Identifier:

NCT01603992

First received: May 19, 2012

Last updated: June 30, 2017

Last verified: May 3, 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

May 19, 2012

Last Updated Date

June 30, 2017

Start Date ^ICMJE

November 8, 2005

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Marijuana Quit Questionnaire [ Time Frame: 1 to 2 hours ]

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT01603992 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Marijuana Craving Questionnaire, and Additional Questions about Marijuana Craving

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms

Official Title ^ICMJE

Quitting Marijuana Use: Self-Report Study of Quitting Strategies and Withdrawal Symptoms

Brief Summary

Background:

- Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment ( spontaneous quitting). Studies have suggested that there are some common strategies that many individuals use in spontaneous quitting, such as changing one s lifestyle or identity, reminding oneself of negative consequences, support from family and friends, and religion. However, more research is needed to determine potential treatment strategies for marijuana use.

Objectives:

To identify strategies used to help with marijuana quitting among non-treatment seeking adult marijuana users.
To identify withdrawal symptoms experienced during marijuana quitting and their relationship to the quitting strategies used and the outcome of the quit attempt.
To evaluate whether subgroups of marijuana users differ in their experience of marijuana quitting.

Eligibility:

- Individuals at least 18 years of age who have made at least one attempt to quit marijuana use.

Design:

The study will consist of one visit of approximately 1 to 2 hours.
Participants will fill out three questionnaires. The questionnaires have different types of questions, and will ask about background and lifestyle, marijuana use and craving patterns and behaviors, and difficulties in previous attempts to quit using marijuana.

Detailed Description

Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment (so-called spontaneous quitting). This study will use two self-report questionnaires to collect information on the socio-demographic characteristics, marijuana use history, most difficult marijuana quit experience, and marijuana craving from a convenience sample of 1230 adult, non-treatment-seeking marijuana users. The questionnaires take 45-60 minutes to administer. Data will be analyzed for patterns and correlations among the characteristics of the quit attempt, including any withdrawal symptoms, quitting strategies used, and its success. The marijuana craving data will be analyzed to evaluate the validity of this measure of marijuana craving. There are no direct benefits to subjects from study participation. The scientific benefit is an improved understanding of spontaneous quitting of marijuana use, which may lead to improved interventions for marijuana users in the future. There are no physical risks to subjects. There are risks of anxiety or embarrassment while taking the questionnaire and of loss of confidentiality of sensitive information collected about subjects.

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Not Provided

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Not Provided

Study Population

Not Provided

Condition ^ICMJE

Cannabis Abuse
Cannabis Dependence

Intervention ^ICMJE

Not Provided

Study Groups/Cohorts

Not Provided

Publications *

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Estimated Enrollment ^ICMJE

1230

Estimated Completion Date

May 3, 2012

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

INCLUSION CRITERIA:
1. age 18 or older
2. have made at least one attempt to quit marijuana use
3. able to give valid informed consent
4. ability to understand English

Sex/Gender

Sexes Eligible for Study:

All

Ages

18 Years and older (Adult, Senior)

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Listed Location Countries ^ICMJE

United States

Removed Location Countries

Administrative Information

NCT Number ^ICMJE

NCT01603992

Other Study ID Numbers ^ICMJE

999906408
06-DA-N408

Has Data Monitoring Committee

Not Provided

U.S. FDA-regulated Product

Not Provided

IPD Sharing Statement

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

David A Gorelick, M.D.

National Institute on Drug Abuse (NIDA)

PRS Account

National Institutes of Health Clinical Center (CC)

Verification Date

May 3, 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top